Health News

Quit Smoking Rx and Your Brain
Medications that help patients quit smoking did not appear to cause serious neuropsychiatric side effects, a new study found.
Cabozantinib Gets Green Light
The US Food and Drug Administration (FDA) has approved a new treatment for advanced kidney cancer.
Breast Cancer Rx and Heart Disease Risk
Researchers have known little about the use of aromatase inhibitors and heart disease risk in breast cancer survivors — until now.
FDA Targets Smokeless Tobacco in Rural Areas
The US Food and Drug Administration (FDA) is expanding its “The Real Cost” campaign to rural America.
Chemotherapy on the Brain
Despite past concerns, a new study found no link between a type of chemotherapy and cognitive decline in breast cancer survivors.
FDA Floats Electric Stimulation Device Ban
Officials at the US Food and Drug Administration (FDA) are calling for a ban of electric stimulation devices used to treat aggressive or self-harming behavior.
How Aspirin Might Affect Cancer Survival
Taking aspirin in low doses could help patients with cancer live longer, a new study found.
Pre-Workout Product Recalled
Nubreed Nutrition, Inc., has issued a voluntary recall for its pre-workout product called Undisputed.
A New Job for Gilotrif
The US Food and Drug Administration has approved Gilotrif (afatinib) to treat squamous cell lung cancer.
Elizabethkingia Anophelis Infections in the US
The CDC and several state health agencies are investigating a multistate outbreak of infections caused by a bacterium called Elizabethkingia anophelis .